Rho activation is required for transforming growth factor‐β‐induced epithelial‐mesenchymal transition in lens epithelial cells

Cell Biology International - Tập 31 - Trang 1225-1230 - 2007
Hee Jun Cho1, Jiyun Yoo1
1Department of Microbiology, Research Institute of Life Science, Gyeongsang National University, Jinju 660-701, South Korea

Tóm tắt

Abstract

Lens epithelial cells undergo epithelial‐mesenchymal transition (EMT) after injury as in cataract extraction, leading to fibrosis of the lens capsule. We have recently shown that TGF‐β‐induced EMT in lens epithelial cells depends on PI3 kinase/Akt signal pathway. In this report, we suggest Smad3 is necessary for TGF‐β‐induced EMT by showing that the expression of dominant‐negative Smad3 blocks the expression of α‐smooth muscle actin (α‐SMA) and morphological changes. We also show that TGF‐β induces a biphasic change in Rho activity, and that Y27632, a selective inhibitor of Rho effector ROCK, inhibits TGF‐β‐induced EMT in vitro and in vivo. We finally show that Smad3 activation and Rho signal activation is independent each other. All of these findings suggest that Rho/ROCK activation together with Smad3 is necessary for TGF‐β‐induced EMT in lens epithelial cells.


Tài liệu tham khảo

10.1016/S0960-9822(00)00537-6 10.1074/jbc.M005912200 10.1242/jcs.115.15.3193 10.1091/mbc.12.1.27 10.1074/jbc.M106176200 10.1016/j.bbrc.2006.12.035 10.1091/mbc.01-08-0398 10.1074/jbc.273.16.9921 10.3109/02713689409015091 10.1126/science.279.5350.509 10.1159/000147748 10.1016/0272-6386(95)90610-X 10.3109/02713689009069932 10.1074/jbc.M005505200 10.1038/eye.1999.126 10.1016/S0165-2478(02)00023-8 10.1242/jcs.112.24.4557 10.1006/exer.1997.0434 10.1006/exer.2001.1002 10.1136/bjo.86.12.1428 10.1167/iovs.02-1059 10.1002/bies.1132 10.1016/0012-1606(90)90278-Q 10.1074/jbc.M009534200 10.1038/nrc1208 10.1006/dbio.2000.9946 10.1152/physrev.2001.81.1.153 10.1002/jcp.10066 10.1038/nrc822 Tian F., 2003, Reduction in Smad2/3 signaling enhances tumorigenesis but suppresses metastasis of breast cancer cell lines, Cancer Res, 63, 8284 10.1006/exer.2002.1175 10.1093/emboj/cdf366 10.1002/aja.1002010409